Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
CRWND as a KC pitch contest winner, Keliah Smith expands her product line (and comfort zone)
Keliah Smith was nervous. She’d never been a fan of speaking in front of a crowd, but knew exposing her discomfort and weakness through the Alchemy Sandbox pitch competition was just part of the ongoing journey of an entrepreneur, she said. Avoiding that spotlight, Smith noted, already had kept her — and her business, CRWND…
DeBruce integrates career toolbox into HBCU’s programming for Black and Brown entrepreneurs
A new partnership between The DeBruce Foundation and Harris-Stowe State University showcases a shared goal of unlocking the potential within individuals and equipping them for bright careers and bright futures, said Leigh Anne Taylor Knight. “This is one of those relationships that reminds us that partnerships don’t need to be complicated,” said Taylor Knight, executive…
Heart by hand: Paper illustrator crafts intricate designs with an evocative pop of culture
Andrea Cira can trace the inspiration for her hand-crafted, colorful, paper illustrations back to her upbringing in Mexico, she shared. “You see a lot of things that are done by hand or by scratch,” she explained. “I’ve lived in different places in Mexico, so I got to see a few things from artisans. I always…
Sleep tech designed to combat night sweats moves toward consumer market with KS bedfellows
A Leawood company’s bed-based sleep technology — designed to reduce night sweats and help people better regulate their temperatures while they sleep — is headed to market in early 2024 with backing from the Kansas angel tax credits program and a swelling pre-seed round, said Win Hansen. Rairflow, Inc., which designed and developed prototypes for…